Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348627 · ClinicalTrials.gov registry record · Phase 3
Opioid-Sparing Joint Replacement
A Phase 3 study, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT07348627 is a Phase 3 study that is actively recruiting participants, run by Emory University. The registered enrollment target is 120 participants.
The verdict
NCT07348627, a Phase 3 study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether an opioid-sparing postoperative pain regimen can reduce opioid consumption and maintain effective pain control in adults undergoing anterior total hip arthroplasty for osteoarthritis. The main questions it aims to answer are: * Does an opioid-limited regimen result in lower postoperative opioid use compared with a standard opioid prescription? * Does the opioid-limited regimen provide comparable or improved postoperative pain control and patient satisfaction?
Interventions
- DRUG Placebo
- DRUG Oxycodone 5 mg
- OTHER Multimodal Non-Opioid Analgesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-03-19 |
| Est. Completion | 2028-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07348627
The ClinicalTrials.gov registry entry for NCT07348627 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07348627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07348627 about?
NCT07348627 is a clinical study titled "Opioid-Sparing Joint Replacement". The goal of this clinical trial is to evaluate whether an opioid-sparing postoperative pain regimen can reduce opioid consumption and maintain effective pain control in adults undergoing anterior total hip arthroplasty for osteoarthritis. The main questions it aims to answer are: * Does an opioid-...
What is the current status of trial NCT07348627?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2026-03-19. Estimated completion is 2028-08.
What interventions are being tested in trial NCT07348627?
The interventions under investigation include: Placebo (DRUG), Oxycodone 5 mg (DRUG), Multimodal Non-Opioid Analgesia (OTHER).
Who is sponsoring clinical trial NCT07348627?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.